Article
Truncated Complement Factor H Y402 Gene Therapy Cures C3 Glomerulonephritis
2024-09-21
Abstract excerpt
Patients with both age-related macular degeneration (AMD) and C3 glomerulonephritis (C3G) are challenged by the absence of effective therapies to reverse and eliminate their disease burden. Capitalizing on complement dysregulation as both a significant risk factor for AMD and the known pathophysiology of C3G, we investigated the potential for adeno-associated virus (AAV) delivery of complement factor H (CFH) to re...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1f1be49c-02a3-5f68-a3ef-750aaeb1543a
- DOI
- 10.1101/2024.09.17.613471
